In this exclusive report, we take a close look at the global Medical Fluid Bags Market. It covers everything from AI-driven supply diagnostics to the implications of non-PVC regulations, along with a range of regional insights. You'll find essential details on competitive benchmarking, market dynamics and evaluations of cutting-edge biocompatible polymers and smart sensor-integrated lifecycles. The global Medical Fluid Bags Market size was valued at US$ 3.89 Billion in 2025 and is poised to grow from US$ 4.08 Billion in 2026 to 6.97 Billion by 2033, growing at a CAGR of 5.43% in the forecast period (2026-2033). This analysis examines product segmentation across intravenous solutions, blood collection systems, parenteral nutrition delivery, and drainage applications, alongside material innovations transitioning from PVC-based compounds to biocompatible polyolefins and thermoplastic polyurethanes.
Market Size (2026)
$3.89B
Projected (2033)
$6.97B
CAGR
5.43%
Published
May 2026
Select User License
Selected
PDF Report
USD 4,900
USD 3,200
The Medical Fluid Bags Market is valued at $3.89B and is projected to grow at a CAGR of 5.43% during 2026 - 2033. North America holds the largest regional share, while Asia-Pacific (8.5%–10.8% CAGR) is the fastest-growing market.
Study Period
2020 - 2033
Market Size (2026)
$3.89B
CAGR (2026 - 2033)
5.43%
Largest Market
North America
Fastest Growing
Asia-Pacific (8.5%–10.8% CAGR)
Market Concentration
Medium
*Disclaimer: Major Players sorted in no particular order
Source: Claritas Intelligence — Primary & Secondary Research, 2026. All market size figures in USD unless otherwise stated.
Global Medical Fluid Bags market valued at $3.89B in 2026, projected to reach $6.97B by 2033 at 5.43% CAGR
Key growth driver: Rising demand for intravenous therapy, dialysis, blood collection and fluid management (High, +1.5% CAGR impact)
North America holds the largest market share, while Asia-Pacific (8.5%–10.8% CAGR) is the fastest-growing region
AI Impact: The Medical Fluid Bags Market is changing because of Artificial Intelligence. Artificial Intelligence is turning plastic bags into smart systems that can think for themselves.
10 leading companies profiled including Baxter International, Coloplast, Thermo Fisher Scientific and 7 more
The Medical Fluid Bags Market is changing because of Artificial Intelligence. Artificial Intelligence is turning plastic bags into smart systems that can think for themselves. This is making a difference in how medical supplies are managed. Now computers can predict when bags will run out and make sure they are stored properly. These computers use networks to check how bags are used and how they are stored. They can even flag bags that are, near expiration or have been damaged by heat.
By 2026 these smart systems will be able to keep patients safe by checking the bags against their records. This will help prevent mistakes with medication and keep everything. Artificial Intelligence is becoming a part of making medical products. It is helping to make sure that bags are made perfectly and do not have any defects. In 2026 machines will be able to check the bags for any flaws that could cause leaks. Artificial Intelligence is also helping to manage the production of blood bags. It can predict when they will be needed most like during emergencies or surgeries.
Moreover Artificial Intelligence is allowing for the simulation of how liquids and plastics interact, which is helping to create fluid-delivery systems. The Medical Fluid Bags Market and Artificial Intelligence are working together to make medical care more efficient and safe. Artificial Intelligence is making the Medical Fluid Bags Market better by helping to prevent mistakes and make sure that medical supplies are available when they are needed. The Medical Fluid Bags Market is a part of the medical industry and Artificial Intelligence is helping it to improve.
The medical fluid bags market has evolved into a highly regulated and material-conscious industry, playing a vital role in both inpatient and outpatient care around the globe. Today, we're seeing a notable shift towards non-PVC and DEHP-free polymer systems, as healthcare providers increasingly prioritize patient safety and environmental sustainability. This change is largely driven by a collective push to eliminate harmful plasticizers, resulting in the widespread use of polypropylene and ethylene-vinyl acetate (EVA) films, which provide excellent chemical compatibility for sensitive pharmaceuticals, including those used in oncology and parenteral nutrition.
A key trend is the rise of advanced multi-chamber bag designs, which enable the precise, shelf-stable storage of complex drug mixtures that can be activated right before administration. Manufacturers are also incorporating smart-labeling and RFID technologies to improve supply chain traceability and minimize medication errors in busy hospital settings. The market is strategically expanding into home-based infusion therapy, focusing on creating portable, durable bags that support long-term management of chronic diseases.
This professional landscape reflects a market that has matured under strict sterility standards and a commitment to sustainability, positioning medical fluid bags as a sophisticated, data-driven element of the healthcare delivery system.
| Year | Market Size (USD Billion) | Period |
|---|---|---|
| 2025 | $3.89B | Historical |
| 2026 | $4.18B | Forecast |
| 2027 | $4.50B | Forecast |
| 2028 | $4.84B | Forecast |
| 2029 | $5.21B | Forecast |
| 2030 | $5.60B | Forecast |
| 2031 | $6.02B | Forecast |
| 2032 | $6.48B | Forecast |
| 2033 | $6.97B | Forecast |
Source: Claritas Intelligence — Primary & Secondary Research, 2026. All market size figures in USD unless otherwise stated.
Base Year: 2025The medical fluid bags market is doing well because of the need for intravenous therapy, dialysis, blood collection and fluid management in hospitals, clinics and home-care settings.
People are using infusion therapies more to manage chronic diseases and take care of themselves after surgery which means they need a steady supply of fluid bags.
The medical fluid bags market is also growing because people are going to outpatient and ambulatory care centers of staying in the hospital and fluid delivery is a big part of their treatment.
The fact that hospitals and clinics follow the procedures and use sterile ready-to-use disposables also helps the medical fluid bags market.
The medical fluid bags need to be sterile not leak and work with types of fluids and medications which means the companies that make them have to be very careful and check them many times.
It can also be hard to change the materials and designs of the bags without confusing the doctors and nurses who use them and without slowing down their work.
Another problem is getting rid of the waste from all the products, which is a concern for healthcare providers.
There are some opportunities in the medical fluid bags market. Because the way healthcare is delivered is changing and products are being improved new chances are coming up. More and more people are getting treated at home. They need fluid bag solutions that are easy to use and can be carried around. Some people prefer fluid bags that are not made of certain materials, like PVC and DEHP which gives companies a chance to make products that are different from others.
Making labels better connecting fluid bags to infusion systems and making them work with automated compounding processes can also help make things safer easier to track and more efficient, in medical settings.
| Region | Market Share | Growth Rate |
|---|---|---|
| North America | 26.2% | 5.6%–6.9%% CAGR |
| Europe | 20.6% | 4.8%–6.3%% CAGR |
| Asia Pacific | 11.8% | 8.5%–10.8%% CAGRFastest |
| Latin America | 18.3% | 3.5%–5.2%% CAGR |
| Middle East & Africa | 23.1% | 4.1%–5.8%% CAGR |
Source: Claritas Intelligence — Primary & Secondary Research, 2026.
Baxter International Coloplast Thermo Fisher Scientific Macopharma B. Braun Medical ConvaTec Fresenius Kabi Smith's medical Pall Corporation Westfield Medical Ltd. These market leaders compete across product innovation, regulatory compliance, and geographic expansion strategies. Baxter International and B. Braun Medical drive market advancement through DEHP-free and PVC-free formulations. Coloplast and ConvaTec expand clinical applications in specialized drainage and infusion systems. Thermo Fisher Scientific and Fresenius Kabi strengthen supply chain integration and pharmaceutical compatibility. Regional players including Macopharma and Westfield Medical focus on localized manufacturing and specialized blood bag technologies.
Competitive differentiation centers on material safety, AI-enabled supply chain management, and home-infusion therapy solutions.
B. Braun Medical Inc (B. Braun), a recognized leader in infusion therapy and pharmaceutical manufacturing, announced the launch of Midazolam in 0.8% Sodium Chloride Injection in the U.S. market. The preservative-free injections will be offered in two strengths 50 mg in 50 mL and 100 mg in 100 mL. Both strengths are packaged in IV bags that are not made with DEHP, PVC or natural rubber latex, placing a priority on patient and environmental safety.
Convatec, a leading medical products and technologies company, is proud to announce clinical study results from a recent multinational randomised controlled trial (RCT) showcasing remarkable advancements in the healing of venous leg ulcers with AQUACEL Ag+ Extra compared to standard of care dressing.
The medical fluid bags market was valued at USD 3.89 billion in 2025 and is forecast to grow to USD 6.97 billion by 2033. This represents a steady market expansion driven by increased demand for safe, regulated fluid management solutions in hospitals and outpatient care facilities globally. See our market size analysis →
The market grows at a CAGR of 5.43% from 2026 to 2033. Growth is primarily driven by the global shift toward non-PVC and DEHP-free polymer systems, coupled with rising demand for patient safety and environmental sustainability in healthcare delivery. See our growth forecast →
Non-PVC and DEHP-free fluid bag segments lead market growth as healthcare providers prioritize eliminating harmful plasticizers. Polypropylene-based and ethyl-based polymer systems are gaining widespread adoption across inpatient and outpatient settings. See our segment analysis →
North America is the largest market for medical fluid bags, reflecting advanced healthcare infrastructure and stringent regulatory frameworks. Asia-Pacific is the fastest-growing region with a 8.5–10.8% CAGR, driven by expanding healthcare capacity and regulatory tightening around plastic safety. See our growth forecast → See our geography analysis →
Leading companies include Baxter International, Coloplast, Thermo Fisher Scientific, Macopharma, and B. Braun Medical. These organizations dominate through innovation in material science, regulatory compliance, and distribution networks serving institutional healthcare customers. See our competitive landscape →
Primary drivers are the regulatory push to eliminate PVC and DEHP plasticizers, and growing healthcare spending in emerging markets. Patient safety concerns and environmental sustainability mandates from healthcare systems are accelerating adoption of safer polymer alternatives globally. See our emerging opportunities →
Supply chain constraints and material cost volatility for non-PVC alternatives create pricing pressures. Regulatory fragmentation across regions and the need for continuous clinical validation of new polymer systems also limit faster market penetration. See our geography analysis →
Emerging opportunities include AI-driven demand forecasting for hospital fluid management, and development of smart fluid bags with IoT integration for real-time patient monitoring. Expansion into Asia-Pacific and emerging healthcare markets presents significant growth potential for established and new entrants. See our emerging opportunities →
How this analysis was conducted
Primary Research
Secondary Research
Access detailed analysis, data tables, and strategic recommendations.